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    n=229 n=128 (55.9%) n=101 (44.1%) P=* 
Gender, n= (%) Male 134 (58.5) 71 (55.5) 63 (62.4) NS 
 
Female 95 (41.5) 57 (44.5) 38 (37.6)   
Age (years) Mean (sd) 39.0 (11.4) 38.6 (11.4) 39.4 (11.4) NS 
Smoking habits, n= (%) Non-smoker 115 (53.0) 68 (55.7) 47 (49.5) 0.06 
  
Current smoker 48 (22.1) 20 (16.4) 28 (29.5)   
  
Ex-smoker 54 (24.9) 34 (27.9) 20 (21.0)   
  
(missing data) 12 
    
  
PA: m (sd) 13.6 (12.4) 14.7 (12.8) 12.5 (11.9) NS 
Atopy, n= (%) No 114 (49.8) 70 (54.7) 44 (43.6) 0.09 
  
Yes 115 (50.2) 58 (45.3) 57 (56.4)   
Low 130 (58.3) 75 (61.0) 55 (55.0) NS Molecular weight of the suspected 
allergen, n= (%) High 93 (41.7) 48 (39.0) 45 (45.0)   
Company size, n= (%) <50 workers 143 (62.5) 73 (57.0) 70 (69.3) 0.06 
   
 50 workers 86 (37.5) 55 (43.0) 31 (30.7)   
Duration of exposure before symptoms 
(years)  Mean (sd) 8.5 (8.7) 8.4 (8.7) 8.6 (8.8) NS 
Duration of symptoms before diagnosis 
(years) Mean (sd) 4.7 (5.7) 3.4 (4.4) 6.3 (6.8) 0.0001 
No 128 (55.9) 83 (64.8) 45 (44.6) 0.02 Treatment by inhaled corticosteroids at diagnosis, n= (%) 
  
Yes 101 (44.1) 45 (35.2) 56 (55.4)   
Symptom score  Mean (sd) 21.2 (7.1) 22.4 (7.5) 19.5 (6.1) 0.01 
FEV1 (as % predicted) Mean (sd) 88.9 (19.2) 95.2 (13.5) 81.0 (22.3) <0.0001 
FEF25-75 (as % predicted) Mean (sd) 71.7 (28.0) 80.6 (24.4) 60.2 (28.4) <0.0001 
FEV1 /FVC x100 Mean (sd) 77.6 (11.4) 80.9 (7.7) 73.3 (13.7) <0.0001 
PD20 methacholine (µg) Mean (sd) 649 (578) 953 (544) 158 (69) <0.0001 
 
Table 1. Characteristics of the sample and bivariate comparisons between mild and moderate-
severe groups of immunologic occupational asthma. 
* Chi-square and Student t tests, NS= not significant,  
FEV1= Forced Expiratory Volume in one second, FEF25-75=Forced Expiratory Flow between 25 and 
75 of Forced Vital Capacity (FVC), PD20 methacholine =provocative dose of methacholine causing a 
20% fall in FEV1. 
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severe group  
    n=229 (100%) n=128 (55.9%) n=101 (44.1%) 
    n = % n = % n = % 
Causes  flour 55 24,0 29 22.7 26 25.7 
  persulfate salts 33 14.4 18 14.1 15 14.9 
  isocyanates 28 12.2 14 10.9 14 13.9 
  latex 16 7,0 9 7,0 7 6.9 
  amines 15 6.6 10 7.8 5 5,0 
  quaternary ammoniums 14 6.1 11 8.6 3 3,0 
  aldehydes 13 5.7 10 7.8 3 3,0 
  mites 11 4.8 4 3.1 7 6.9 
  
resins & glues (isocyanates 
excluded) 
8 3.5 3 2.3 5 5,0 
  laboratory animals  5 2.2 3 2.3 2 2,0 
  pollens 5 2.2 3 2.3 2 2,0 
  others  26 11.3 14 11.1 12 11.7 
Jobs bakers and pastry makers 53 23.1 28 21.9 25 24.8 
  hairdressers 37 16.2 21 16.4 16 15.8 
  health workers 24 10.5 14 10.9 10 9.9 
  cleaners 22 9.6 13 10.2 9 8.9 
  painters (mainly spray painters) 13 5.7 6 4.7 7 6.9 
  laboratory technicians 6 2.6 4 3.1 2 2,0 
  wood workers 7 3.1 3 2.3 4 4,0 
  welders 5 2.2 2 1.6 3 3,0 
  others 62 27,0 37 28.9 25 24.7 
 
Table 2. Distribution of causes and jobs in the study population. 
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 Total Probable OA Definite OA 
    n=229 n=167 (72.9%) n=62 (27.1%) p=* 
Gender, n= (%) Male 134 (58.5) 96 (57.5) 38 (61.3) NS 
  
Female 95 (41.5) 71 (42.5) 24 (38.7)   
Age (years) Mean (sd) 39.0 (11.4) 38.9 (11.4) 39.1 (11.5) NS 
Smoking habits, n= (%) Non-smoker 115 (53.0) 87 (56.1) 28 (45.2) NS 
  
Current smoker 48 (22.1) 33 (21.3) 15 (24.2)   
  
Ex-smoker 54 (24.9) 35 (22.6) 19 (30.7)   
  
(missing data) 12 
    
  
PA: m (sd) 13.6 (12.4) 12.8 (12.8) 15.3 (11.5) NS 
Atopy, n= (%) No 114 (49.8) 80 (47.9) 34 (54.8) NS 
  
Yes 115 (50.2) 87 (52.1) 28 (45.2) NS 
Low 130 (58.3) 91 (55.8) 39 (65.0) NS Molecular weight of the suspected allergen,  
n= (%) High 93 (41.7) 72 (44.2) 21 (35.0)   
Company size, n= (%) <50 workers 143 (62.5) 107 (64.1) 36 (58.1) NS 
   
 50 workers 86 (37.5) 60 (35.9) 26 (41.9)   
Duration of exposure before symptoms (years) Mean (sd) 8.5 (8.7) 8.2 (8.2) 9.2 (10.0) NS 
Duration of symptoms before diagnosis (years)  Mean (sd) 4.7 (5.7) 4.8 (5.9) 4.4 (5.2) NS 
No 128 (55.9) 95 (56.9) 33 (53.2) NS Treatment by inhaled corticosteroids at 
diagnosis, n= (%) Yes 101 (44.1) 72 (43.1) 29 (46.8)   
Symptom score  Mean (sd) 21.2 (7.1) 21.3 (7.7) 20.9 (5.7) NS 
FEV1 (as % predicted) Mean (sd) 88.9 (19.2) 89.0 (19.7) 88.7 (18.0) NS 
FEF25-75 (as % predicted) Mean (sd) 71.7 (28.0) 73.1 (28.9) 67.8 (25.5) NS 
FEV1 /FVC x100 Mean (sd) 77.6 (11.4) 77.6 (12.1) 77.6 (9.0) NS 
PD20 methacholine (µg) Mean (sd) 649 (578) 647 (576) 654 (589) NS 
Severity group Mild group 167 (72.9) 93 (55.7) 35 (56.5) NS 
  
Moderate-severe 
group 62 (27.1) 74 (44.3) 27 (43.5)   
Positive immunologic testing No 55 (37.7) 41 (36.9) 14 (40.0) NS 
  IgE or skin-prick test  91 (62.3) 70 (63.1) 21 (60.0)   
  
(missing data) 83       
 
Table 3. Comparisons of the characteristics of subjects with probable and definite 
occupational asthma (OA) 
* Chi-square and Student t tests, NS= not significant 
FEV1= Forced Expiratory Volume in one second, FEF25-75=Forced Expiratory Flow between 25 and 
75 of Forced Vital Capacity (FVC), PD20 methacholine =provocative dose of methacholine causing a 
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 aOR [95% CI]  
    (for moderate-severe OA) p 
Gender Male 1 NS 
  
Female 0.85 [0.46-1.57]   
Age (years) Mean (sd) 0.99 [0.96-1.02] NS 
Smoker (present and ex) No 1 NS 
  
Yes 1.09 [0.60-2.00]   
Atopy No 1 NS 
  
Yes 1.39 [0.73-2.66]   
Molecular weight of causal allergen Low 1 NS 
  
High 0.82 [0.42-1.60]   
Duration of exposure before symptoms (years) Mean (sd) 1.01 [0.97-1.05] NS 
Duration of symptoms before diagnosis (years) Mean (sd) 1.12 [1.05-1.19] 0.0004 
Treatment by inhaled corticosteroids at diagnosis No 1 0.04 
 
Yes 1.83 [1.01-3.33]   
Symptom score  Mean (sd) 0.93 [0.89-0.98] 0.01 
Table 4. Multivariate analyses using a logistic model based on severity of immunologic 
occupational asthma (OA). 
NS= not significant 
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